Literature DB >> 16339676

Thalassemia and learning: Neurocognitive functioning in children.

F Daniel Armstrong1.   

Abstract

As more effective management and even cure of thalassemia become possible, attention is beginning to be directed to the potential neurologic and resulting neurocognitive effects of this illness on adults and children. Recent studies indicate that for adults with beta-thalassemia major and intermedia, and for children with sickle beta-thalassemia (Sbeta-thalassemia), there is a substantial risk for silent brain infarcts that may be associated with neurocognitive impairment similar to that reported for children with sickle cell anemia. Here the available literature in this area is reviewed and the limited outcomes are compared with those available from large, multicenter longitudinal studies of sickle cell anemia. On the basis of these comparisons, it is recommend that children with thalassemia be screened for specific neuropsychological impairments and that they be provided early intervention and special education access as available under the Individuals with Disabilities Education Act (IDEA) or the 504 Regulations of the Rehabilitation Act of 1973.

Entities:  

Mesh:

Year:  2005        PMID: 16339676     DOI: 10.1196/annals.1345.036

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction.

Authors:  Michael L Nieder; George B McDonald; Aiko Kida; Sangeeta Hingorani; Saro H Armenian; Kenneth R Cooke; Michael A Pulsipher; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-01       Impact factor: 5.742

2.  Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias.

Authors:  Chau Vu; Adam Bush; Soyoung Choi; Matthew Borzage; Xin Miao; Aart J Nederveen; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2021-05-12       Impact factor: 13.265

3.  Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity.

Authors:  Jirapas Sripetchwandee; Noppamas Pipatpiboon; Nipon Chattipakorn; Siriporn Chattipakorn
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.